Marino R, Ratti F, Della Corte A, Santangelo D, Clocchiatti L, Canevari C, et al. Comparing liver venous deprivation and portal vein embolization for perihilar cholangiocarcinoma: is it time to shift the focus to hepatic functional reserve rather than hypertrophy? Cancers (Basel). 2023;15(17):4363.
Gomez D, Malik HZ, Bonney GK, Wong V, Toogood GJ, Lodge JPA, et al. Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br J Surg. 2007;94(11):1395–402.
Article CAS PubMed Google Scholar
Bilhim T, Böning G, Guiu B, Luz JH, Denys A. CIRSE standards of practice on portal vein embolization and double vein embolization/liver venous deprivation. Cardiovasc Intervent Radiol. 2024;47(8):1025–36.
Article PubMed PubMed Central Google Scholar
Schadde E, Raptis DA, Schnitzbauer AA, Ardiles V, Tschuor C, Lesurtel M, et al. Prediction of mortality after ALPPS stage-1. Ann Surg. 2015;262:780–6.
Schadde E, Ardiles V, Robles-Campos R, Malago M, Machado M, Hernandez-Alejandro R, et al. Early survival and safety of ALPPS first report of the international ALPPS registry. Ann Surg. 2014;260:829–38.
Guiu B, Quenet F, Panaro F, Piron L, Cassinotto C, Herrerro A, et al. Liver venous deprivation versus portal vein embolization before major hepatectomy: future liver remnant volumetric and functional changes. Hepatobil Surg Nutr. 2020;9:564–76.
Kobayashi K, Yamaguchi T, Denys A, Perron L, Halkic N, Demartines N, et al. Liver venous deprivation compared to portal vein embolization to induce hypertrophy of the future liver remnant before major hepatectomy: a single center experience. Surgery. 2020;167:917–23.
Korenblik R, Olij B, Aldrighetti LA, Hilal MA, Ahle M, Arslan B, et al. Dragon 1 protocol manuscript: training, accreditation, implementation and safety evaluation of portal and hepatic vein embolization (PVE/HVE) to accelerate future liver remnant (FLR) hypertrophy. Cardiovasc Intervent Radiol. 2022;45:1391–8.
Article CAS PubMed PubMed Central Google Scholar
Deshayes E, Piron L, Bouvier A, Lapuyade B, Lermite E, Ver- vueren L, et al. Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study com- paring simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy. BMC Cancer. 2020. https://doi.org/10.1186/s12885-020-07065-z.
Article PubMed PubMed Central Google Scholar
Graffy PM, Pickhardt PJ. Quantification of hepatic and visceral fat by CT and MR imaging: relevance to the obesity epidemic, metabolic syndrome and NAFLD. Br J Radiol. 2016;89(1062):20151024.
Article PubMed PubMed Central Google Scholar
Guarneri G, Palumbo D, Pecorelli N, Prato F, Gritti C, Cerchione R, et al. The impact of CT-assessed liver steatosis on postoperative complications after pancreaticoduodenectomy for cancer. Ann Surg Oncol. 2022;29(11):7063–73.
Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Int J Surg. 2014;12(12):1500–24.
Della Corte A, Santangelo D, Augello L, Ratti F, Cipriani F, Canevari C, et al. Single-center retrospective study comparing double vein embolization via a trans-jugular approach with liver venous deprivation via a trans-hepatic approach. Cardiovasc Intervent Radiol. 2023;46(12):1703–12.
Kodama Y, Ng CS, Wu TT, Ayers GD, Curley SA, Abdalla EK, et al. Comparison of CT methods for determining the fat content of the liver. Am J Roentgenol. 2007;188(5):1307–12.
Starekova J, Hernando D, Pickhardt PJ, Reeder SB. Quantification of liver fat content with CT and MRI: state of the art. Radiology. 2021;301(2):250–62.
Vauthey JN, Chaoui A, Do KA, Bilimoria MM, Fenstermacher MJ, Charnsangavej C, et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery. 2000;127(5):512–9.
Article CAS PubMed Google Scholar
de Graaf W, van Lienden KP, Dinant S, Roelofs JJTH, Busch ORC, Gouma DJ, et al. Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection. J Gastrointest Surg. 2010;14:369–78.
Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL. Cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Intervent Radiol. 2017;40:1141–6.
Article CAS PubMed Google Scholar
Boubaddi M, Marichez A, Adam JP, Lapuyade B, Debordeaux F, Tlili G, et al. Comprehensive review of future liver remnant (FLR) assessment and hypertrophy techniques before major hepatectomy: how to assess and manage the FLR. Ann Surg Oncol. 2024;31(13):9205–20.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications. Ann Surg. 2004;240(2):205–13.
Article PubMed PubMed Central Google Scholar
Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, et al. Posthepatectomy liver failure: a definition and grading by the international study group of liver surgery (ISGLS). Surgery. 2011;149:713–24.
Hitpass L, Amygdalos I, Sieben P, Raaff V, Lang S, Bruners P, et al. MRI-based quantitation of hepatic steatosis does not predict hypertrophy rate after portal vein embolization in patients with colorectal liver metastasis and normal to moderately elevated fat fraction. J Clin Med. 2021;10(9):2003.
Article CAS PubMed PubMed Central Google Scholar
Barth BK, Fischer MA, Kambakamba P, Lesurtel M, Reiner CS. Liver-fat and liver-function indices derived from Gd-EOB-DTPA-enhanced liver MRI for prediction of future liver remnant growth after portal vein occlusion. Eur J Radiol. 2016;85(4):843–9.
Dash A, Figler RA, Sanyal AJ, Wamhoff BR. Drug-induced steatohepatitis. Expert Opin Drug Metab Toxicol. 2017;13(2):193–204.
Article CAS PubMed Google Scholar
Guiu B, Deshayes E, Panaro F, Sanglier F, Cusumano C, Herrerro A, et al. 99mTc-mebrofenin hepatobiliary scintigraphy and volume metrics before liver preparation: correlations and discrepancies in non-cirrhotic patients. Ann Transl Med. 2021;9(9):795–795.
Article CAS PubMed PubMed Central Google Scholar
Björk D, Carling U, Gilg S, Hasselgren K, Larsen PN, Lindell G, et al. Hyperbilirubinemia does not impair induced liver hypertrophy after portal vein Embolization—a retrospective scandinavian cohort study. Eur J Surg Oncol. 2025;51(7): 109995.
De Beukelaer F, Van den Bosch V, Kuhl C, Pedersoli F, Bruners P. Comparison of complications in patients with ductal cholangiocarcinoma (CCC) and patients with colorectal liver metastases (CRLMS) after portal vein embolization (PVE): a matched cohort study. Cardiovasc Intervent Radiol. 2024;47(9):1257–64.
Crawford JM, Bioulac-Sage P, Hytiroglou P. Structure, function, and responses to injury. In Amsterdam: Elsevier; 2018. https://doi.org/10.1016/B978-0-7020-6697-9.00001-7.
Fagenson AM, Pitt HA, Moten AS, Karhadkar SS, Di Carlo A, Lau KN. Fatty liver: the metabolic syndrome increases major hepatectomy mortality. Surgery. 2021;169(5):1054–60.
McCormack L, Petrowsky H, Jochum W, Furrer K, Clavien PA. Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy. Ann Surg. 2007;245(6):923–30.
Comments (0)